KNOREX Ltd. (KNRX) Trading Suspended Amid Delisting Proceedings

NYSE American suspended trading in KNOREX Ltd.'s (KNRX) shares and began delisting proceedings due to low share price. The company plans to appeal, and trading will remain halted during the process.

Original reporting
Published Nov 12, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 1:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
KNOREX Ltd. (KNRX) Trading Suspended Amid Delisting Proceedings — source image
Decision brief

The 30-second read

$KNRXBearishMed
01

Why it matters

The immediate suspension eliminates trading, likely triggering sell pressure and forcing holders to liquidate via alternative venues or wait for a possible reverse split.

02

Market read

The news is highly relevant for traders with exposure to KNRX, as it creates an immediate liquidity event and potential price decline.

03

What to watch

Potential hidden cash reserves or strategic assets that could make the company an acquisition target despite the delisting.

Relevance 6/10Novelty 7/10Timing: effective immediately

Background

KNOREX Ltd. is a micro‑cap listed on NYSE American; its share price fell below exchange minimums, prompting a suspension and delisting process.

Company-level read

Ticker impact

$KNRXBearishHigh confidence
Context

Trading of KNOREX Ltd. (KNRX) was suspended on NYSE American and delisting proceedings were initiated due to a low share price.

Expected impact

likely pressure as the market prices in the delisting risk and loss of tradability

Evidence & confidence

A trading halt and delisting process are immediate catalysts that typically depress a stock's price and deter investors.

Market effects

Minimal; the event is company‑specific and does not affect the broader sector.

Limited to investors holding or tracking micro‑cap U.S. equities.

Low; no broader macro or geopolitical implications.

Counterpoint

If the appeal succeeds and a reverse split restores listing, the stock could rebound on short‑covering.

Key entities

  • KNOREX Ltd.

    Issuer of the suspended Class A ordinary shares.

  • NYSE American

    Venue that suspended trading and initiated delisting proceedings.

Related articles

$MARAMed

MARA prices $185M debt offering after $1.1B Bitcoin sale

MARA priced an $185M debt offering at 8.75% interest, maturing in 2032, to finance its $1.5B acquisition of Long Ridge Energy. The deal includes a 485MW power plant and land for potential data centers. MARA recently sold $1.1B in Bitcoin to repay debt. Long Ridge generated $144M in annualized adjusted EBITDA, but interest payments may consume nearly half.

$RIOLow

Rio Tinto commits US$250m to address damage from Bougainville's Panguna mine

Rio Tinto will contribute $250m to a fund addressing environmental and human rights impacts of the Panguna mine, per an agreement with Bougainville Copper Limited, the Autonomous Bougainville Government, and community leaders. The fund aims to support practical responses to identified impacts and social projects. Details will be developed in consultation with communities.

$PLCEMed

The Children’s Place begins nationwide closing sales as the future of hundreds of stores remains uncertain

The Children's Place has begun nationwide closing sales across its 500 stores in the U.S. and Canada, following a Chapter 11 bankruptcy filing. The retailer is seeking a buyer to potentially preserve operations. Gymboree, also owned by the company, is included in the liquidation. Sales are ongoing in stores and online, with gift cards and rewards valid until Dec. 12, 2026. The company aims to complete the sale process by the end of December, but the future of stores and brands remains uncertain.

$SNTMed

Insurer Santam Grows 10% as Returns Slip

Santam, a South African insurer, reported 10% growth in premiums for the nine months ending September 2026, but investment returns fell to 2.5% from 3% due to weaker markets. The company's underwriting margin improved since June, staying within its 5%-10% target. Sanlam, which holds 63% of Santam, offered R505 per share to acquire the remaining shares, with the deal expected to close in Q1 2027. Santam's share price is currently 2.8% below the offer price.